Search by Drug Name or NDC

    NDC 00067-8205-01 Theraflu Flu Relief Max Strength 1000; 4; 30 mg/30mL; mg/30mL; mg/30mL Details

    Theraflu Flu Relief Max Strength 1000; 4; 30 mg/30mL; mg/30mL; mg/30mL

    Theraflu Flu Relief Max Strength is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE.

    Product Information

    NDC 00067-8205
    Product ID 0067-8205_61898c20-fbf7-4d08-bb32-9bc248da25d5
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Theraflu Flu Relief Max Strength
    Proprietary Name Suffix Nighttime
    Non-Proprietary Name Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 1000; 4; 30
    Active Ingredient Units mg/30mL; mg/30mL; mg/30mL
    Substance Name ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-8205-01 (00067820501)

    NDC Package Code 0067-8205-01
    Billing NDC 00067820501
    Package 245.5 mL in 1 BOTTLE (0067-8205-01)
    Marketing Start Date 2022-06-27
    NDC Exclude Flag N
    Pricing Information N/A